| Risk parameters | Our results of statistical analysis | Studies confirming a significant risk for incidence of metastases |
| T stage and tumour size | Significant | Haisma [8], Wermken [9], Thompson [10], Cherpelis [11], Clark [12], Rowe [26], Zeng [28], Jambusaria-Pahlajani [30], Lehnerdt [31], Quaedvlieg [32], Roozeboom [33] |
| Tumour recurrence | Significant | Wermken [9], Cherpelis [11], Moore [34] |
| Depth of infiltration | Significant | Haisma [8], Wermken [9], Thompson [10], Cherpelis [11], Brougham [16], Rowe [26], Leibovitch [27], Brantsch [35], Lehnerdt [31], Quaedvlieg [32], Roozeboom [33] |
| Subcutaneous infiltration | Significant | Wermken [9], Cherpelis [11], Clark [12], Jambusaria-Pahlajani [30], Moore [34], Quaedvlieg [32] |
| Positive resection margins | Significant | Wermken [9], Lee [36], Ch’ng [37], Quaedvlieg [32], Genders [38], Mourouzis [39], |
| Close resection margins | Not significant | Jenkins [40], Stratigos [41] |
| Poor differentiation | Not significant | Haisma [8], Wermken [9], Clark [12], Brougham [16], Vauterin [22], Rowe [26], Zeng [28], Jambusaria-Pahlajani [30], Karia [37], Lehnerdt [31], Moore [34], Quaedvlieg [32] |
| Desmoplastic type | Not evaluated | Breuninger [42] |
| Actinic keratosis | Not significant | Cherpelis [11], Rowe [26], Moore [34], Quaedvlieg [32], Del Regno [43] | Inflammation | Scarring | Irradiation |
| Temple location | Significant | Haisma [8], Thompson [10], Brougham [16] |
| Ear location | Not significant | Haisma [8], Wermken [9], Thompson [10], Rowe [26], Brantsch [35], Karia [44], Lehnerdt [31], |
| Perineural invasion | Not evaluated | Thompson [10], Cherpelis [11], Brougham [16], Rowe [26], Jambusaria-Pahlajani [30], Ch’ng [37], Karia [44], Moore [34], Quaedvlieg [32], Lin [45], Carter [46] |
| Angioinvasion | Not evaluated | Quaedvlieg [32] |
| Immunosuppression | Not evaluated | Cherpelis [11], Rowe [26], Venables [47], Tokez [48], Ch’ng [37] |
| Lymphatic invasion | Not evaluated | Moore [34] |
|
|